These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29575534)

  • 1. Perioperative management of children with glycogen storage disease type II-Pompe disease.
    Bosman L; Hoeks SE; González Candel A; van den Hout HJM; van der Ploeg AT; Staals LM
    Paediatr Anaesth; 2018 May; 28(5):428-435. PubMed ID: 29575534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANESTHESIA MANAGEMENT IN AN INFANT WITH GLYCOGEN STORAGE DISEASE TYPE II (POMPE DISEASE).
    Al Atassi A; Al Zughaibi N; Naeim A; Al Basha A; Dimitriou V
    Middle East J Anaesthesiol; 2015 Oct; 23(3):343-6. PubMed ID: 26860026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of immune tolerance induction in restoration of the efficacy of ERT in Pompe disease.
    Lacaná E; Yao LP; Pariser AR; Rosenberg AS
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):30-9. PubMed ID: 22253234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature pubarche in children with Pompe disease.
    Tan QK; Stockton DW; Pivnick E; Choudhri AF; Hines-Dowell S; Pena LD; Deimling MA; Freemark MS; Kishnani PS
    J Pediatr; 2015 Apr; 166(4):1075-8.e1. PubMed ID: 25687635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series.
    Wang LY; Ross AK; Li JS; Dearmey SM; Mackey JF; Worden M; Corzo D; Morgan C; Kishnani PS
    Paediatr Anaesth; 2007 Aug; 17(8):738-48. PubMed ID: 17596219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infantile Pompe disease on ERT: update on clinical presentation, musculoskeletal management, and exercise considerations.
    Case LE; Beckemeyer AA; Kishnani PS
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):69-79. PubMed ID: 22252989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and adaptive functioning of children with infantile Pompe disease treated with enzyme replacement therapy: long-term follow-up.
    Spiridigliozzi GA; Heller JH; Kishnani PS
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):22-9. PubMed ID: 22253038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anesthetic management for a child with pompe disease].
    Sato Y; Yamaguchi K; Miwa T; Hiroki K
    Masui; 2007 Mar; 56(3):324-5. PubMed ID: 17366920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal polysomnographic findings in infantile Pompe disease.
    Kansagra S; Austin S; DeArmey S; Kazi Z; Kravitz RM; Kishnani PS
    Am J Med Genet A; 2015 Apr; 167A(4):858-61. PubMed ID: 25706820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease].
    Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ
    Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pompe disease: early diagnosis and early treatment make a difference.
    Chien YH; Hwu WL; Lee NC
    Pediatr Neonatol; 2013 Aug; 54(4):219-27. PubMed ID: 23632029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into therapeutic options for Pompe disease.
    Richard E; Douillard-Guilloux G; Caillaud C
    IUBMB Life; 2011 Nov; 63(11):979-86. PubMed ID: 22002928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infantile-onset Pompe disease: Diagnosis and management.
    Bay LB; Denzler I; Durand C; Eiroa H; Frabasil J; Fainboim A; Maxit C; Schenone A; Spécola N
    Arch Argent Pediatr; 2019 Aug; 117(4):271-278. PubMed ID: 31339275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low anal sphincter tone in infantile-onset Pompe Disease: an emerging clinical issue in enzyme replacement therapy patients requiring special attention.
    Tan QK; Cheah SM; Dearmey SM; Kishnani PS
    Mol Genet Metab; 2013 Feb; 108(2):142-4. PubMed ID: 23266370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme replacement therapy for infantile Pompe disease during the critical period and identification of a novel mutation.
    But WM; Lee SH; Chan AO; Lau GT
    Hong Kong Med J; 2009 Dec; 15(6):474-7. PubMed ID: 19966354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pompe disease: design, methodology, and early findings from the Pompe Registry.
    Byrne BJ; Kishnani PS; Case LE; Merlini L; Müller-Felber W; Prasad S; van der Ploeg A
    Mol Genet Metab; 2011 May; 103(1):1-11. PubMed ID: 21439876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical therapy management of Pompe disease.
    Case LE; Kishnani PS
    Genet Med; 2006 May; 8(5):318-27. PubMed ID: 16702883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study.
    van der Ploeg A; Carlier PG; Carlier RY; Kissel JT; Schoser B; Wenninger S; Pestronk A; Barohn RJ; Dimachkie MM; Goker-Alpan O; Mozaffar T; Pena LD; Simmons Z; Straub V; Guglieri M; Young P; Boentert M; Baudin PY; Wens S; Shafi R; Bjartmar C; Thurberg BL
    Mol Genet Metab; 2016 Sep; 119(1-2):115-23. PubMed ID: 27473031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysomnographic findings in infantile Pompe disease.
    Kansagra S; Austin S; DeArmey S; Kishnani PS; Kravitz RM
    Am J Med Genet A; 2013 Dec; 161A(12):3196-200. PubMed ID: 24123966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractures in children with Pompe disease: a potential long-term complication.
    Case LE; Hanna R; Frush DP; Krishnamurthy V; DeArmey S; Mackey J; Boney A; Morgan C; Corzo D; Bouchard S; Weber TJ; Chen YT; Kishnani PS
    Pediatr Radiol; 2007 May; 37(5):437-45. PubMed ID: 17342521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.